Actavis sues U.S. drug regulator over generic Celebrex

[Reuters] – Actavis Plc said on Monday it has sued the U.S. Food and Drug Administration, challenging its decision to award exclusive rights to Teva Pharmaceutical Industries Ltd to sell a generic version of Pfizer Inc’s blockbuster painkiller Celebrex. more

View todays social media effects on ABBV

View the latest stocks trending across Twitter. Click to view dashboard

See who AbbVie is hiring next, click here to view